Gene Therapy Market to be Worth $10.0 Billion by 2028 with CAGR of 20.4%: Grand View Research, Inc.

SAN FRANCISCO, Aug. 11, 2022 /PRNewswire/ -- The global gene therapy market size is expected to reach USD 10.0 billion by 2028 registering a CAGR of 20.4% during the forecast period, according

Related Keywords

Australia ,California ,United States ,Canada ,Russia ,Grand View ,San Francisco ,America ,American ,Kostenloser Wertpapierhandel ,Gensight Biologics ,Oxford Biomedica ,Asia Pacific ,Bio Zynteglo ,Sherry James ,Regenxbio Inc ,Epeius Biotechnologies Corp ,Taxus Cardium Pharmaceuticals Group Inc ,Shanghai Sunway Biotech Co Ltd ,Bristol Myers Squibb Company ,View Research Helps Fortune ,Benitec Biopharma Ltd ,Sangamo Therapeutics Inc ,Astellas Pharma Inc ,View Research ,Shire Plc ,Bluebird Bio Inc ,Roche Ltd ,Genetic Technologies Corporation ,Biomarin Pharmaceuticals Inc ,Gilead Lifesciences Inc ,Dimension Therapeutics Inc ,View Research Inc ,Sibiono Genetech Co Ltd ,Calimmune Inc ,View Research Biotechnology Industry ,Grand View Research ,Industry Insights ,Largeb Cell ,Acute Lymphoblastic Leukemia ,North America ,Therapy Market Size ,Trends Analysis Report By Indication ,Largeb Cell Lymphoma ,Vector Type ,Segment Forecasts ,Bluebird Bio ,Therapy Market ,Lymphoblastic Leukemia ,Muscular Atrophy ,Type Outlook ,Key Players ,Gene Therapy ,Cardium Pharmaceuticals Group ,Damarin Pharmaceuticals ,Gene Therapy Manufacturing Market ,Expression Market ,Synthesis Market ,Biotechnology Industry Research ,Grand View Research Helps Fortune ,Sales Specialist ,View Compass ,Gene ,Therapy ,Market ,North ,Billion ,028 ,Agr ,Brand ,View ,Research ,